Literature DB >> 31987360

Correction to: "Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up".

D Planchard, S Popat, K Kerr, S Novello, E F Smit, C Faivre-Finn, T S Mok, M Reck, P E Van Schil, M D Hellmann, S Peters.   

Abstract

Entities:  

Year:  2019        PMID： 31987360     DOI： 10.1093/annonc/mdy474

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  83 in total

1.  High-dose Radiotherapy for Oligo-progressive NSCLC Receiving EGFR Tyrosine Kinase Inhibitors: Real World Data.

Authors:  Mariacarmela Santarpia; Giuseppe Altavilla; Nicolo Borsellino; Andrea Girlando; Gianfranco Mancuso; Stefano Pergolizzi; Dario Piazza; Antonio Pontoriero; Maria Rosaria Valerio; Vittorio Gebbia
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

2.  A Prognostic Score for Brain Metastases of Non-small-cell Lung Cancer in the Era of Precision Medicine.

Authors:  Hua-Shai Hsu; Sung-Lin Hu; Chun-Ru Chien
Journal:  Lung       Date:  2019-06-29       Impact factor: 2.584

3.  Clinical outcomes and predictive value of programmed cell death-ligand 1 expression in response to anti-programmed cell death 1/ligand 1 antibodies in non-small cell lung cancer patients with performance status 2 or greater.

Authors:  Takayuki Jodai; Koichi Saruwatari; Tokunori Ikeda; Eiji Moriyama; Kosuke Kashiwabara; Naoki Shingu; Kazuhiro Iyonaga; Megumi Inaba; Yusuke Ajishi; Chiharu Honda; Susumu Hirosako; Hirotaka Maruyama; Yosuke Kakiuchi; Hirofumi Eida; Yusuke Tomita; Sho Saeki; Hidenori Ichiyasu; Takuro Sakagami
Journal:  Int J Clin Oncol       Date:  2020-09-23       Impact factor: 3.402

4.  Inter-tumor heterogeneity of PD-L1 expression in non-small cell lung cancer.

Authors:  Yuichi Saito; Sho Horiuchi; Hiroaki Morooka; Takayuki Ibi; Nobumasa Takahashi; Tomohiko Ikeya; Yoshihiko Shimizu; Eishin Hoshi
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

5.  Real-World Treatment Patterns, Epidermal Growth Factor Receptor (EGFR) Testing and Outcomes in EGFR-Mutated Advanced Non-small Cell Lung Cancer Patients in Belgium: Results from the REVEAL Study.

Authors:  Kristof Cuppens; Liesbet Lodewyckx; Ingel Demedts; Lore Decoster; Benoît Colinet; Koen Deschepper; Annelies Janssens; Daniella Galdermans; Thierry Pieters
Journal:  Drugs Real World Outcomes       Date:  2021-03-12

Review 6.  Advances in multimodal treatment for stage IIIA-N2 non-small cell lung cancer.

Authors:  Sara Montemuiño Muñiz; Soraya Marcos Sánchez; Julia Calzas Rodríguez; Beatriz Losada Vila; Esther Llorente Herrero; María Dolores Hisado Díaz; Victoria Valeri-Busto González; Begoña Taboada Valladares; Blanca Vaquero Barrón; Francisco José Marcos Jimenez; Sergio Amor Alonso; Javier Moradiellos; Núria Rodríguez de Dios; Felipe Couñago
Journal:  J Clin Transl Res       Date:  2021-04-16

7.  Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion.

Authors:  Silvia La Monica; Roberta Minari; Daniele Cretella; Mara Bonelli; Claudia Fumarola; Andrea Cavazzoni; Maricla Galetti; Graziana Digiacomo; Federica Riccardi; Pier Giorgio Petronini; Marcello Tiseo; Roberta Alfieri
Journal:  Target Oncol       Date:  2019-10       Impact factor: 4.493

8.  Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Real-World Data from an Academic Central and Eastern European Center.

Authors:  Marija Ivanović; Lea Knez; Ana Herzog; Mile Kovačević; Tanja Cufer
Journal:  Oncologist       Date:  2021-08-02

Review 9.  Upfront Management of ALK-Rearranged Metastatic Non-small Cell Lung Cancer: One Inhibitor Fits All?

Authors:  Fabrizio Tabbò; Francesco Passiglia; Silvia Novello
Journal:  Curr Oncol Rep       Date:  2021-01-02       Impact factor: 5.075

10.  Taqman-MGB nanoPCR for Highly Specific Detection of Single-Base Mutations.

Authors:  Zhenrui Xue; Minli You; Ping Peng; Haoyang Tong; Wanghong He; Ang Li; Ping Mao; Ting Xu; Feng Xu; Chunyan Yao
Journal:  Int J Nanomedicine       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.